Q Sciences isn't selling vitamins—it's selling a $392M promise of wellness that customers are actively rejecting. With a 1.8/5 Trustpilot rating, this isn't a company that needs better products; it needs a fundamental business model reckoning.

"When you're making $392M but can't crack 15K monthly visitors, you're not selling products—you're managing a downline."

The tech stack tells a story of ambition without execution. They're using Tailwind CSS, Bootstrap, and Ant Design simultaneously—a Frankenstein's monster of frontend frameworks that screams 'we hired three different dev teams who didn't talk to each other.' Vite and PWA suggest they wanted a modern app experience, but with 14K visits, the investment is wildly disproportionate to the user base.

• Revenue-to-traffic ratio of 27,000% suggests a pure distributor model, not retail
• 1.8/5 Trustpilot score indicates systemic product or business model failure
• 100% US concentration creates single-point-of-failure risk
• Top keyword 'rejuvia' (1,290 searches) outperforms brand terms 7x—product awareness > brand awareness